until at least 2032, when the first main patent for the drug, held by Novo Nordisk,expires
This initial dose is generally sub-therapeutic for glycaemic control
And on April 1, the Food and Drug Administration (FDA) approved Foundayo (orforglipron), a pill for adults with obesity or who are overweight and have a weight-related medical condition
Mounjaro is the name brand of tirzepatide approved for diabetes treatment
Compared with other oral hypoglycemic agents, the prevalence of PD when using DPP4 inhibitors and GLP-1RAs was shown to be 36-60% lower (76)
According to American Thyroid Association guidelines, treatment is typically initiated when TSH rises above 10 mIU/L or when TSH is between 4.5-10 mIU/L with symptoms or positive thyroid antibodies